New R01 Grants for Cancer Nanotechnology



NCI’s Office of Cancer Nanotechnology Research has published a new funding opportunity announcement for the Innovative Research in Cancer Nanotechnology (IRCN) initiative, PAR-17-240. All IRCN awards made through this announcement will be part of the Alliance for Nanotechnology in Cancer network. Due dates are twice per year, with the announcement remaining open until May 2020. The first due date is November 21, 2017.